Current interventions in the management of knee osteoarthritis.

J Pharm Bioallied Sci. 2013 Jan; 5(1): 30-8
Bhatia D, Bejarano T, Novo M

Osteoarthritis (OA) is progressive joint disease characterized by joint inflammation and a reparative bone response and is one of the top five most disabling conditions that affects more than one-third of persons > 65 years of age, with an average estimation of about 30 million Americans currently affected by this disease. Global estimates reveal more than 100 million people are affected by OA. The financial expenditures for the care of persons with OA are estimated at a total annual national cost estimate of $ 15.5-$ 28.6 billion per year. As the number of people >65 years increases, so does the prevalence of OA and the need for cost-effective treatment and care.… Continue reading →